Quality control in the apoA-I secretory pathway

Quality control in the apoA-I secretory pathway

From a total of 47 known apolipoprotein A-I (apoA-I) mutations, only 18 are linked to low plasma HDL apoA-I concentrations, and 78% of these map to apoA-I helices 6 and 7 (residues 143–186). Gene transfer and transgenic mouse studies have shown that several helix 6 apoA-I mutations have reduced hepa...

Full description

Bibliographic Details
Main Authors:	Shaila Bhat, Manal Zabalawi, Mark C. Willingham, Gregory S. Shelness, Michael J. Thomas, Mary G. Sorci-Thomas
Format:	Article
Language:	English
Published:	Elsevier 2004-07-01
Series:	Journal of Lipid Research
Subjects:	apolipoprotein A-I high density lipoprotein mutant apolipoprotein A-I protein secretion quality control pathway aggresomes
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520317776

Similar Items

Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance?
by: Manal Zabalawi, et al.
Published: (2007-01-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin
by: John S. Owen, et al.
Published: (2007-01-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells
by: Nassrin Dashti, et al.
Published: (2004-10-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01)

ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity
by: Márcia Almeida Liz, et al.
Published: (2007-11-01)

ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL
by: Jeffrey W. Chisholm, et al.
Published: (2002-01-01)

Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins
by: Marian C. Cheung, et al.
Published: (2006-06-01)

Increased methionine sulfoxide content of apoA-I in type 1 diabetes
by: Jonathan W.C. Brock, et al.
Published: (2008-04-01)

Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro
by: Veneracion G. Cabana, et al.
Published: (2004-02-01)

Three-dimensional models of HDL apoA-I: implications for its assembly and function*
by: Michael J. Thomas, et al.
Published: (2008-09-01)

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
by: Marie-Claude Blatter Garin, et al.
Published: (2006-03-01)

Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes1
by: David Masson, et al.
Published: (2006-02-01)

Probing the C-terminal domain of lipid-free apoA-I demonstrates the vital role of the H10B sequence repeat in HDL formation
by: Xiaohu Mei, et al.
Published: (2016-08-01)

Circulating HDL levels control hypothalamic astrogliosis via apoA-I
by: Anna Götz, et al.
Published: (2018-09-01)

Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers[S]
by: Mary G. Sorci-Thomas, et al.
Published: (2012-09-01)

Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse
by: Makiko Umezawa, et al.
Published: (2003-04-01)

Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mices⃞
by: Yunlong Wang, et al.
Published: (2008-08-01)

A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation
by: Conxita Jacobs-Cachá, et al.
Published: (2021-05-01)

HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney
by: Ji-Young Lee, et al.
Published: (2005-10-01)

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice1
by: Shen Qu, et al.
Published: (2007-07-01)

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
by: Frank G. Schaap, et al.
Published: (2006-10-01)

Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney
by: Patrizia Tarugi, et al.
Published: (1998-04-01)

On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway
by: Maki Tsujita, et al.
Published: (2005-01-01)

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Studys⃞
by: Erdembileg Anuurad, et al.
Published: (2007-03-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines
by: Larbi Krimbou, et al.
Published: (2005-08-01)

Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01)

Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice
by: Matthijs Moerland, et al.
Published: (2007-12-01)

Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake
by: Jessica P. Otis, et al.
Published: (2015-03-01)

A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
by: Pia Davidsson, et al.
Published: (2005-09-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01)

Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice
by: Hideru Obinata, et al.
Published: (2019-11-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
by: Konstantina Georgila, et al.
Published: (2019-08-01)

A novel approach to oral apoA-I mimetic therapy[S]
by: Arnab Chattopadhyay, et al.
Published: (2013-04-01)

Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
by: Katsunori Ikewaki, et al.
Published: (2004-07-01)

Cannot write session to /tmp/vufind_sessions/sess_ht6mq7h9ilenev2i0odiopbttg